C12R 2001/45
Staphylococcus epidermidis
C12R2001/45 (Staphylococcus epidermidis) appears on 11 US grants and 23 published applications in this corpus.
Search patents in C12R- Granted patents
- 11
- Published applications
- 23
- Assignees
- 17
- Inventors
- 55
- Latest grant
- 23 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 3 |
| 2017 | 4 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 1 |
| 2020 | 1 | 0 |
| 2021 | 1 | 2 |
| 2022 | 0 | 5 |
| 2023 | 0 | 2 |
| 2024 | 0 | 4 |
| 2025 | 1 | 2 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Auxotrophic strains of Staphylococcus bacterium23 Dec 2025US 12,503,691 B2Azitra Inc
- Auxotrophic strains of staphylococcus bacterium22 Jun 2021US 11,041,217 B2Azitra Inc
- Bacterium-contained hydrogel and method of making the same14 Apr 2020US 10,617,769 B2Tci Co., Ltd.
- Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof20 Jun 2017US 9,681,665 B2Sami Labs Limited
- Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof20 Jun 2017US 9,681,666 B2Sami Labs Limited
- Composition for caring for keratin materials, comprising at least indole-3-lactic acid, indole-3-carboxaldehyde, indole-3-acetic acid and an adjuvant, uses and process implementing the composition23 Jul 2026US 2026/0207457 A1L'oreal
- Treatment of organic waste29 Jan 2026US 2026/0028293 A1Biomax Holdings PTE LTD
- Optimized culture media for clostridia bacteria28 Aug 2025US 2025/0270498 A1Janssen Biotech, Inc.
- Auxotrophic strains of staphylococcus bacterium6 Feb 2025US 2025/0043237 A1Azitra Inc
- Molecular bacteriotherapy to control skin enzymatic activity3 Oct 2024US 2024/0325460 A1The Regents of the University of California
Most cited
By later US patents
- Bacterium-contained hydrogel and method of making the same20US 10,617,769 B2Tci Co., Ltd. · 2020
- Antibiotic polypeptide compounds prepared from staphlococcus bacteria3US 4,448,714 A1984
- Antibiotic compounds, process for the preparation and pharmaceutical compositions thereof, methods of treatment therewith and Staphylococcus bacteria3US 4,588,692 A1986
- Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof2US 9,596,861 B2Sami Labs Limited · 2017